This inventor holds 3 USPTO granted patents. Top assignee: Applera Corporation. Active years: 2004-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2005
Title: The Innovations of Xiangjun Liu
Introduction
Xiangjun Liu is a prominent inventor based in Olney, MD (US). He has made significant contributions to the field of genetics and autoimmune diseases. With a total of 3 patents, his work has advanced the understanding of genetic polymorphisms and their implications in various health conditions.
Latest Patents
One of Liu's latest patents is focused on polymorphisms in known genes associated with inflammatory autoimmune diseases. This invention is based on the discovery of novel single nucleotide polymorphisms (SNPs) that contribute to these disorders. The patent provides reagents for detecting and expressing the variant nucleic acid/protein sequences, as well as methods for identifying and utilizing these variants. Another significant patent addresses polymorphisms in genes associated with osteoporosis. Similar to his work on autoimmune diseases, this invention also identifies novel SNPs that can lead to various disorders mediated by osteoporosis-associated proteins.
Career Highlights
Xiangjun Liu is affiliated with Applera Corporation, where he continues to innovate and contribute to scientific research. His work has been instrumental in developing methods that enhance the detection and understanding of genetic variations linked to health conditions.
Collaborations
Liu has collaborated with notable scientists, including J Craig Venter and Jinghui N Zhang. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
Xiangjun Liu's contributions to the field of genetics and autoimmune diseases through his patents highlight his role as a leading inventor. His work not only advances scientific knowledge but also has the potential to improve health outcomes for individuals affected by these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
